Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Neuropharmacology|August 29, 2019
Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptorsAstrid S Obrecht, Nicole Urban, Michael Schaefer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 11, 2010
Trophic activity of a naturally occurring truncated isoform of the P2X7 receptorElena Adinolfi, Maria Cirillo, Ronja Woltersdorf, et al.
Frontiers in Pharmacology|April 3, 2023
Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptorLaura Grohs, Linhan Cheng, Saskia Cönen, et al.
Scientific Reports|October 28, 2015
Impaired surface membrane insertion of homo- and heterodimeric human muscle chloride channels carrying amino-terminal myotonia-causing mutationsKatharina Ronstedt, Damien Sternberg, Silvia Detro-Dassen, et al.
Journal of Medicinal Chemistry|October 28, 2005
Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potencyHeiko Ullmann, Sabine Meis, Darunee Hongwiset, et al.
Molecular Pharmacology|December 31, 2010
Molecular determinants of potent P2X2 antagonism identified by functional analysis, mutagenesis, and homology dockingChristian Wolf, Christiane Rosefort, Ghada Fallah, et al.
ACS Chemical Neuroscience|March 18, 2021
LncRNA UC.360+ shRNA Improves Diabetic Cardiac Sympathetic Dysfunction Mediated by the P2X4 Receptor in the Stellate GanglionLiran Shi, Minghao Sun, Xinlu Ren, et al.
ACS Chemical Neuroscience|January 31, 2023
Gallic Acid Improves Comorbid Chronic Pain and Depression Behaviors by Inhibiting P2X7 Receptor-Mediated Ferroptosis in the Spinal Cord of RatsRunan Yang, Liran Shi, Han Si, et al.
Frontiers in Pharmacology|June 19, 2023
Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptorLaura Grohs, Linhan Cheng, Saskia Cönen, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 10, 2009
NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cellsSabine Meis, Alexandra Hamacher, Darunee Hongwiset, et al.
Pageof 8